6505-01-649-0647 Diphenhydramine hydrochloride in
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 25, 2026
- Last price paid
- …
- Standard price
- $82.38 per BX
- DLA's catalog price, not a price paid
- Approved sources
- 1
- One approved manufacturer listed
- Awards on record
- 110
- 2018 to 2026
- DLA demand
- –
Identification
- Item name
- Diphenhydramine hydrochloride in
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 16-OCT-15
- Unit
- BX
- NSN
- 6505-01-649-0647
- NIIN
- 01-649-0647
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| FRESENIUS KABI, LLC | 57KZ6 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC76045-0102-10 | DLA approved-source file |
| 64616 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 6505NCM152416 | FLIS part list | |
| 89875 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | 1376697 | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
3 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D9900 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $19,999,999 | March 6, 2038 | INDEFINITE DELIVERY / REQUIREMENTS | No | 23 | October 16, 2026 |
| SPE2DX25D9822 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $20,000,000 | March 6, 2035 | INDEFINITE DELIVERY / REQUIREMENTS | No | 28 | September 8, 2026 |
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 2 | April 30, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004909280 (Antihistamines in meas doses /pkg rtal sale)
- PINC
- 0009327
- Criticality (CRIT CD)
- X
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| MC55 | Marine Corps (DM) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 3From the actual manufacturer (second or later time) | ZCommercial or off-the-shelf item | ||||
| ZH01 | Republic of korea (ZH) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | BX | $39.71 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | BX | $39.71 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Marine Corps (DM) | 14-JUL-2026 | BX | $39.71 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | BX | $39.71 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | BX | $82.38 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0434DIBBS only | 6505-01-649-0647 | Diphenhydramine hydrochloride in | 1 | BX | $82.38 per BX | … | … | No set-aside | No | November 19, 2026 | November 25, 20265 days left |
→ These RFQs in the DIBBS list
Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
110 award lines since 2018, 1 winning CAGE
| Winner | Awards | Last award |
|---|---|---|
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 110 | November 16, 2026 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 53 | 1 |
| 2025 | 31 | 1 |
| 2024 | 13 | 1 |
| 2023 | 4 | 1 |
| 2021 | 6 | 1 |
| 2020 | 1 | 1 |
| 2018 | 2 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | DMS PHARMACEUTICAL GROUP INC | $8,608 | 96 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2D226F3283From the item's award history | August 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F3238From the item's award history | August 10, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F3214From the item's award history | August 7, 2026 | DMS PHARMACEUTICAL GROUP INC | $174 |
| SPE2D226F3188From the item's award history | August 5, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F3183From the item's award history | August 4, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F3119From the item's award history | July 30, 2026 | DMS PHARMACEUTICAL GROUP INC | $130 |
| SPE2DP26F7958From the item's award history | July 22, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2D226F3065From the item's award history | July 20, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F3011From the item's award history | July 14, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2DP26F7592From the item's award history | July 14, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2DP26F7259From the item's award history | July 9, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2DP26F7117From the item's award history | July 6, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2DP26F6986From the item's award history | July 2, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2DP26F6855From the item's award history | June 30, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2DP26F6802From the item's award history | June 25, 2026 | DMS PHARMACEUTICAL GROUP INC | $434 |
| SPE2D226F2865From the item's award history | June 23, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2858From the item's award history | June 22, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2820From the item's award history | June 15, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2792From the item's award history | June 8, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2774From the item's award history | June 4, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2740From the item's award history | June 1, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2643From the item's award history | May 26, 2026 | DMS PHARMACEUTICAL GROUP INC | $43 |
| SPE2D226F2535From the item's award history | May 13, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2D226F2447From the item's award history | May 5, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
| SPE2D226F2150From the item's award history | April 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $87 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.